METHODE ELECTRONICS INC - Quarter Report: 2022 July (Form 10-Q)

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)


☒	Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the quarterly period ended July 30, 2022


☐	Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from ______ to ______

Commission file number 001-33731

METHODE ELECTRONICS, INC.

(Exact name of registrant as specified in its charter)


Delaware	36-2090085
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
8750 West Bryn Mawr Avenue, Suite 1000, Chicago, Illinois	60631-3518
(Address of principal executive offices)	(Zip Code)

(Registrant’s telephone number, including area code) (708) 867-6777

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each Class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.50 Par Value	MEI	New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At August 26, 2022, the registrant had 36,574,090 shares of common stock outstanding.

Table of Contents

METHODE ELECTRONICS, INC.

INDEX


		Page

PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements

	Condensed Consolidated Statements of Income (unaudited) - Three Months Ended July 30, 2022 and July 31, 2021	2

	Condensed Consolidated Statements of Comprehensive Income (unaudited) - Three Months Ended July 30, 2022 and July 31, 2021	3

	Condensed Consolidated Balance Sheets as of July 30, 2022 (unaudited) and April 30, 2022	4

	Condensed Consolidated Statements of Shareholders’ Equity (unaudited) - Three Months Ended July 30, 2022 and July 31, 2021	5

	Condensed Consolidated Statements of Cash Flows (unaudited) - Three Months Ended July 30, 2022 and July 31, 2021	6

	Notes to Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	27

Item 4.	Controls and Procedures	27

PART II.	OTHER INFORMATION

Item 1A.	Risk Factors	28

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28

Item 6.	Exhibits	28

SIGNATURES		29

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(in millions, except per share data)


	Three Months Ended
	July 30, 2022			July 31, 2021
Net sales	$	282.4		$	287.8

Cost of products sold		220.6			216.1

Gross profit		61.8			71.7

Selling and administrative expenses		35.3			32.8
Amortization of intangibles		4.7			4.8

Income from operations		21.8			34.1

Interest expense, net		—			1.1
Other income, net		(4.1	)		(1.8	)

Income before income taxes		25.9			34.8

Income tax expense		4.4			5.7

Net income	$	21.5		$	29.1

Basic and diluted income per share:
Basic	$	0.59		$	0.77
Diluted	$	0.58		$	0.76

Cash dividends per share	$	0.14		$	0.14

See notes to condensed consolidated financial statements.

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in millions)


	Three Months Ended
	July 30, 2022			July 31, 2021
Net income	$	21.5		$	29.1

Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments		(10.9	)		(4.1	)
Derivative financial instruments		1.5			0.9
Total comprehensive income	$	12.1		$	25.9

See notes to condensed consolidated financial statements.

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share and per-share data)


	July 30, 2022			April 30, 2022
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	152.4		$	172.0
Accounts receivable, net		282.0			273.3
Inventories		173.9			158.5
Income taxes receivable		7.7			8.3
Prepaid expenses and other current assets		23.1			16.9
Total current assets		639.1			629.0
Long-term assets:
Property, plant and equipment, net		194.6			197.0
Goodwill		232.7			233.0
Other intangible assets, net		202.6			207.7
Operating lease right-of-use assets, net		18.2			20.0
Deferred tax assets		36.2			36.8
Pre-production costs		26.5			27.2
Other long-term assets		40.0			38.4
Total long-term assets		750.8			760.1
Total assets	$	1,389.9		$	1,389.1

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	116.4		$	108.5
Accrued employee liabilities		26.8			30.0
Other accrued liabilities		27.6			24.5
Short-term operating lease liabilities		5.6			6.0
Short-term debt		13.0			13.0
Income tax payable		6.4			6.6
Total current liabilities		195.8			188.6
Long-term liabilities:
Long-term debt		194.2			197.5
Long-term operating lease liabilities		13.5			14.8
Long-term income taxes payable		22.1			22.1
Other long-term liabilities		15.6			14.0
Deferred tax liabilities		37.3			38.3
Total long-term liabilities		282.7			286.7
Total liabilities		478.5			475.3
Shareholders' equity:
Common stock, $0.50 par value, 100,000,000 shares authorized, 38,001,714 shares and 38,276,968 shares issued as of July 30, 2022 and April 30, 2022, respectively		19.0			19.2
Additional paid-in capital		172.0			169.0
Accumulated other comprehensive loss		(36.2	)		(26.8	)
Treasury stock, 1,346,624 shares as of July 30, 2022 and April 30, 2022		(11.5	)		(11.5	)
Retained earnings		768.1			763.9
Total shareholders' equity		911.4			913.8
Total liabilities and shareholders' equity	$	1,389.9		$	1,389.1

See notes to condensed consolidated financial statements.

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited)

(in millions, except share data)


	Three Months Ended July 30, 2022
	Common stock shares			Common stock			Additional paid-in capital		Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity
Balance as of April 30, 2022		38,276,968		$	19.2		$	169.0	$	(26.8	)	$	(11.5	)	$	763.9		$	913.8
Issuance of restricted stock, net of tax withholding		42,381			—			—		—			—			(0.4	)		(0.4	)
Purchases of common stock		(317,635	)		(0.2	)		—		—			—			(11.7	)		(11.9	)
Stock-based compensation expense		—			—			3.0		—			—			—			3.0
Other comprehensive loss		—			—			—		(9.4	)		—			—			(9.4	)
Net income		—			—			—		—			—			21.5			21.5
Dividends on common stock		—			—			—		—			—			(5.2	)		(5.2	)
Balance as of July 30, 2022		38,001,714		$	19.0		$	172.0	$	(36.2	)	$	(11.5	)	$	768.1		$	911.4


	Three Months Ended July 31, 2021
	Common stock shares			Common stock			Additional paid-in capital			Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity
Balance as of May 1, 2021		39,644,913		$	19.8		$	157.6		$	6.1		$	(11.5	)	$	746.0		$	918.0
Issuance of restricted stock, net of tax withholding		44,245			0.1			(0.1	)		—			—			(0.3	)		(0.3	)
Exercise of stock options		13,000			—			0.5			—			—			—			0.5
Purchases of common stock		(157,513	)		(0.1	)		—			—			—			(7.5	)		(7.6	)
Stock-based compensation expense		—			—			3.2			—			—			—			3.2
Other comprehensive income		—			—			—			(3.2	)		—			—			(3.2	)
Net income		—			—			—			—			—			29.1			29.1
Dividends on common stock		—			—			—			—			—			(5.4	)		(5.4	)
Balance as of July 31, 2021		39,544,645		$	19.8		$	161.2		$	2.9		$	(11.5	)	$	761.9		$	934.3

See notes to condensed consolidated financial statements.

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)


	Three Months Ended
	July 30, 2022			July 31, 2021
Operating activities:
Net income	$	21.5		$	29.1
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		12.3			12.6
Stock-based compensation expense		4.0			4.0
Change in cash surrender value of life insurance		0.2			(0.4	)
Amortization of debt issuance costs		0.2			0.2
Gain on sale of property, plant and equipment		—			(0.4	)
Change in deferred income taxes		(1.8	)		(0.1	)
Other		—			0.1
Changes in operating assets and liabilities:
Accounts receivable		(11.9	)		4.7
Inventories		(17.4	)		(18.5	)
Prepaid expenses and other assets		(4.3	)		(5.0	)
Accounts payable		10.5			(8.1	)
Other liabilities		(0.6	)		(8.5	)
Net cash provided by operating activities		12.7			9.7

Investing activities:
Purchases of property, plant and equipment		(9.6	)		(15.9	)
Sale of property, plant and equipment		—			0.5
Net cash used in investing activities		(9.6	)		(15.4	)

Financing activities:
Taxes paid related to net share settlement of equity awards		(0.5	)		(0.3	)
Repayments of finance leases		(0.1	)		(0.2	)
Proceeds from exercise of stock options		—			0.5
Purchases of common stock		(11.9	)		(8.4	)
Cash dividends		(5.0	)		(5.2	)
Repayments of borrowings		(3.3	)		(4.7	)
Net cash used in financing activities		(20.8	)		(18.3	)
Effect of foreign currency exchange rate changes on cash and cash equivalents		(1.9	)		(1.3	)
Decrease in cash and cash equivalents		(19.6	)		(25.3	)
Cash and cash equivalents at beginning of the period		172.0			233.2
Cash and cash equivalents at end of the period	$	152.4		$	207.9

Supplemental cash flow information:
Cash paid during the period for:
Interest	$	0.8		$	0.9
Income taxes, net of refunds	$	5.6		$	7.3
Operating lease obligations	$	1.9		$	1.9

See notes to condensed consolidated financial statements.

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1. Description of Business and Summary of Significant Accounting Policies

Description of business

Methode Electronics, Inc. (the “Company” or “Methode”) is a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. The Company designs, engineers and produces mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing its broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

The Company’s solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment, consumer appliance and medical devices.

Impact of the COVID-19 pandemic and supply chain disruptions

The COVID-19 pandemic and the ongoing measures to reduce its spread have negatively impacted the global economy, disrupted consumer and customer demand and global supply chains, and resulted in manufacturing inefficiencies and increased freight costs due to global capacity constraints. As a result of a resurgence of the virus in China and corresponding government lock-down orders, the COVID-19 pandemic had a negative impact on the Company's China operations in the three months ended July 30, 2022. Further resurgences of the COVID-19 virus or its variants in other regions, including corresponding lock-downs or similar government orders, could also impact the Company's results of operations.

Various government programs have been enacted to provide assistance to businesses impacted by the COVID-19 pandemic. The amount of assistance the Company received was $4.1 million and $1.9 million in the three months ended July 30, 2022 and July 31, 2021, respectively. Government assistance has been reported as other income.

The Company continues to experience increased material and logistics costs, labor shortages, and most significantly, impacts from the worldwide semiconductor supply shortage. The semiconductor supply shortage is due, in part, to increased demand across multiple industries, including the automotive industry, resulting in a slowdown in their production schedules. The semiconductor supply shortage is also impacting the Company’s supply chain and its ability to meet demand at some of its non-automotive customers.

The Russia-Ukraine military conflict has negatively impacted the Company's European customers and suppliers. Although the Company does not have any operations in Russia, economic sanctions imposed by the international community has further increased existing supply chain, logistics, and inflationary challenges.

Basis of presentation

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). All intercompany balances and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments, except as otherwise disclosed) that management believes are necessary for a fair presentation of the results of operations, financial position and cash flows of the Company for the interim periods presented. These financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Form 10-K for the year ended April 30, 2022, filed with the SEC on June 23, 2022. Results may vary from quarter to quarter for reasons other than seasonality.

Financial reporting periods

The Company maintains its financial records on the basis of a 52- or 53-week fiscal year ending on the Saturday closest to April 30. The three months ended July 30, 2022 and July 31, 2021 were both 13-week periods.

Use of estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from these estimates.

Table of Contents

Summary of significant accounting policies

The Company’s significant accounting policies are described in Note 1, “Description of Business and Summary of Significant Accounting Policies,” to the consolidated financial statements included in the Company’s Form 10-K for the year ended April 30, 2022. There have been no material changes to the significant accounting policies in the three months ended July 30, 2022.

New accounting pronouncements not yet adopted

In November 2021, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2021-10, “Government Assistance (Topic 832),” which requires annual disclosures when an entity has received government assistance. This guidance is intended to improve the transparency of government assistance received by requiring disclosure of: (1) the types of government assistance received; (2) the accounting for such assistance; and (3) the effect of the assistance on the registrant’s financial statements. The Company will adopt this standard effective April 29, 2023 and expects the standard to only impact annual financial statement footnote disclosures.

Note 2. Revenue

The Company generates revenue from the manufacturing of products for customers in diversified global markets. The substantial majority of the Company’s revenue is recognized at a point in time. The Company has determined that the most definitive demonstration that control of the product has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer’s usage.

Revenue associated with products which the Company believes have no alternative use (such as highly customized parts), and where the Company has an enforceable right to payment, are recognized on an over time basis. Revenue is recognized based on progress to date, which is typically even over the production process through transfer of control to the customer.

From time to time, customers may negotiate annual price downs. Management has evaluated these price downs and determined that in some instances, these price downs give rise to a material right. In instances that a material right exists, a portion of the transaction price is allocated to the material right and recognized over the life of the contract.

Across all products, the amount of revenue recognized corresponds to the related purchase order and is adjusted for variable consideration (such as discounts). Sales and other taxes collected concurrent with revenue-producing activities are excluded from revenue.

The Company’s performance obligations are typically short-term in nature. As a result, the Company has elected the practical expedient that provides an exemption from the disclosure requirements regarding information about remaining performance obligations on contracts that have original expected durations of one year or less.

Contract balances

A contract asset is an entity’s right to consideration in exchange for goods or services that the entity has transferred to a customer. A contract liability exists when an entity has received consideration, or the amount is due from the customer in advance of revenue recognition. The net changes in the contract asset and contract liability balances for the three months ended July 30, 2022 and July 31, 2021 were not material.

Disaggregated revenue information

The following table represents a disaggregation of revenue from contracts with customers by segment and geographical location. Net sales are attributed to regions based on the location of production. Though revenue recognition patterns and contracts are generally consistent, the amount, timing and uncertainty of revenue and cash flows may vary in each reportable segment due to geographic and economic factors.

Table of Contents


	Three Months Ended July 30, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	94.7	$	40.7	$	13.0	$	0.7	$	149.1
EMEA		52.1		28.5		—		—		80.6
Asia		29.8		22.9		—		—		52.7
Total net sales	$	176.6	$	92.1	$	13.0	$	0.7	$	282.4
Timing of revenue recognition:
Goods transferred at a point in time	$	172.1	$	92.1	$	13.0	$	0.7	$	277.9
Goods transferred over time		4.5		—		—		—		4.5
Total net sales	$	176.6	$	92.1	$	13.0	$	0.7	$	282.4


	Three Months Ended July 31, 2021
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	99.1	$	42.4	$	12.5	$	0.8	$	154.8
EMEA		57.8		19.8		—		—		77.6
Asia		38.9		16.3		0.2		—		55.4
Total net sales	$	195.8	$	78.5	$	12.7	$	0.8	$	287.8
Timing of revenue recognition:
Goods transferred at a point in time	$	189.7	$	78.5	$	12.7	$	0.8	$	281.7
Goods transferred over time		6.1		—		—		—		6.1
Total net sales	$	195.8	$	78.5	$	12.7	$	0.8	$	287.8

Note 3. Income Taxes

The provision for income taxes for an interim period is based on an estimated annual effective income tax rate applied to ordinary year-to-date earnings or losses. The estimated annual effective income tax rate is determined excluding the effects of unusual or significant one-time items that are reported net of the related tax effects in the period in which they occur. In addition, any material effects of enacted tax law or rate changes as well as the Company’s ability to utilize various tax assets is recognized in the period in which the change occurs.

The computation of the estimated annual effective income tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pre-tax income (or loss) for the year by jurisdiction, certain book to tax adjustments, and the likelihood of the realizability of deferred tax assets generated in the current year. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as the Company’s tax environment changes.

The Company’s income tax expense and effective tax rate for the three months ended July 30, 2022 and July 31, 2021 were as follows:


	Three Months Ended
($ in millions)	July 30, 2022			July 31, 2021
Income before income taxes	$	25.9		$	34.8
Income tax expense	$	4.4		$	5.7
Effective tax rate		17.0	%		16.4	%

The effective tax rate for the three months ended July 30, 2022 was lower than the U.S. statutory tax rate primarily due income derived from foreign operations with lower statutory tax rates partially offset by non-deductible expenses. The effective tax rate for the three months ended July 31, 2021 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates.

The Company’s gross unrecognized income tax benefits were $5.1 million as of both July 30, 2022 and April 30, 2022. If any portion of the Company’s unrecognized tax benefits is recognized, it would impact the Company’s effective tax rate. The unrecognized tax benefits are reviewed periodically and adjusted for changing facts and circumstances, such as tax audits, the lapsing of applicable statutes of limitations and changes in tax law. The Company recognizes interest and penalties related to income tax uncertainties in income tax expense. Accrued interest and penalties were $0.3 million and $0.2 million as of July 30, 2022 and April 30, 2022, respectively.

Table of Contents

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was enacted in the United States. The IR Act imposes a 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. The Company is assessing the potential impact of the stock repurchase excise tax, but based on its preliminary assessment, the Company does not expect a material impact on its consolidated financial statements. Further, the remaining corporate tax changes included in the IR Act are not expected to have a material impact on the Company’s consolidated financial statements.

Note 4. Balance Sheet Components

Cash and cash equivalents

Cash and cash equivalents consist of cash and highly liquid investments with maturities of three months or less. Highly liquid investments include money market funds which are classified within Level 1 of the fair value hierarchy. As of July 30, 2022 and April 30, 2022, the Company had a balance of $40.1 million and $40.0 million, respectively, in money market accounts.

Accounts receivable and allowance for doubtful accounts

Accounts receivable are customer obligations due under normal trade terms and are presented net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on the current expected credit loss impairment model. The Company applies a historical loss rate based on historic write-offs to aging categories. The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts of future losses as necessary. The Company may also record a specific reserve for individual accounts when it becomes aware of specific customer circumstances, such as in the case of a bankruptcy filing or deterioration in the customer’s operating results or financial position. The allowance for doubtful accounts balance was $1.0 million as of both July 30, 2022 and April 30, 2022.

Inventories

Inventories are stated at the lower-of-cost or net realizable value. Cost is determined using the first-in, first-out method. Finished products and work-in-process inventories include direct material costs and direct and indirect manufacturing costs. The Company records reserves for inventory that may be obsolete or in excess of current and future market demand. A summary of inventories is shown below:


(in millions)	July 30, 2022		April 30, 2022
Finished products	$	38.0	$	31.8
Work in process		13.0		12.9
Raw materials		122.9		113.8
Total inventories	$	173.9	$	158.5

Property, plant and equipment

Property, plant and equipment is stated at cost. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method using estimated useful lives of 5 to 40 years for buildings and building improvements and 3 to 15 years for machinery and equipment. A summary of property, plant and equipment is shown below:


(in millions)	July 30, 2022			April 30, 2022
Land	$	3.1		$	3.3
Buildings and building improvements		89.5			89.2
Machinery and equipment		402.5			407.5
Construction in progress		27.1			21.5
Total property, plant and equipment, gross		522.2			521.5
Less: accumulated depreciation		(327.6	)		(324.5	)
Property, plant and equipment, net	$	194.6		$	197.0

Depreciation expense was $7.6 million and $7.8 million in the three months ended July 30, 2022 and July 31, 2021, respectively. As of July 30, 2022 and April 30, 2022, capital expenditures recorded in accounts payable totaled $3.4 million and $4.4 million, respectively.

Table of Contents

Pre-production tooling costs related to long-term supply arrangements

The Company incurs pre-production tooling costs related to products produced for its customers under long-term supply arrangements. Engineering, testing and other costs incurred in the design and development of production parts are expensed as incurred, unless the costs are reimbursable by the customer. As of July 30, 2022 and April 30, 2022, the Company had $26.5 million and $27.2 million, respectively, of pre-production tooling costs related to customer-owned tools for which reimbursement is contractually guaranteed by the customer or for which the customer has provided a non-cancelable right to use the tooling.

Costs for molds, dies and other tools used in products produced for its customers under long-term supply arrangements for which the Company has title are capitalized in property, plant and equipment and amortized over the shorter of the life of the arrangement or over the estimated useful life of the assets. As of July 30, 2022 and April 30, 2022, Company-owned tooling was $13.2 million and $14.6 million, respectively.

Note 5. Goodwill and Other Intangible Assets

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. A summary of the changes in the carrying amount of goodwill, by segment, is shown below:


(in millions)	Automotive			Industrial			Total
Balance as of April 30, 2022	$	105.9		$	127.1		$	233.0
Foreign currency translation		(0.2	)		(0.1	)		(0.3	)
Balance as of July 30, 2022	$	105.7		$	127.0		$	232.7

The Company tests goodwill and indefinite-lived intangible assets for impairment on an annual basis as of the beginning of the fourth quarter each fiscal year. In addition, the Company continuously monitors for events and circumstances that could negatively impact the key assumptions used in determining fair value and therefore require interim goodwill impairment testing, including long-term revenue growth projections, profitability, discount rates, volatility in the Company's market capitalization, and general industry, market and macroeconomic conditions. No impairment indicators were identified in the first quarter of fiscal 2023.

Other intangible assets, net

Details of identifiable intangible assets are shown below:


	As of July 30, 2022
(in millions)	Gross		Accumulated amortization			Net		Weighted average useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	231.8	$	(58.1	)	$	173.7		14.5
Trade names, patents and technology licenses		57.9		(30.8	)		27.1		6.0
Total amortized intangible assets		289.7		(88.9	)		200.8
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	291.5	$	(88.9	)	$	202.6


	As of April 30, 2022
(in millions)	Gross		Accumulated amortization			Net		Weighted average useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	232.3	$	(55.1	)	$	177.2		14.7
Trade names, patents and technology licenses		58.0		(29.3	)		28.7		6.2
Total amortized intangible assets		290.3		(84.4	)		205.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	292.1	$	(84.4	)	$	207.7

Table of Contents

Based on the current amount of intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years and thereafter is as follows:


(in millions)
Fiscal Year:
Remainder of 2023	$	14.1
2024		18.5
2025		17.9
2026		17.0
2027		16.4
Thereafter		116.9
Total	$	200.8

Note 6. Derivative Instruments and Hedging Activities

The Company is exposed to various market risks including, but not limited to, foreign currency exchange rates and market interest rates. The Company strives to control its exposure to these risks through our normal operating activities and, where appropriate, through the use of derivative financial instruments. Derivative financial instruments are measured at fair value on a recurring basis.

For a designated cash flow hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded in accumulated other comprehensive income (“AOCI”) in the condensed consolidated balance sheets. When the underlying hedged transaction is realized, the gain or loss previously included in AOCI is recorded in earnings and reflected in the condensed consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. The gain or loss associated with changes in the fair value of derivatives not designated as hedges are recorded immediately in the condensed consolidated statements of income on the same line as the associated risk. For a designated net investment hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded as a cumulative translation adjustment in AOCI in the condensed consolidated balance sheets.

Net investment hedges

The Company has a variable-rate, cross-currency swap, maturing on August 31, 2023, with a notional value of $60.0 million (€54.8 million). The Company entered into the cross-currency swap to mitigate changes in net assets due to changes in U.S. dollar-euro spot exchange rates. The cross-currency swap is designated as a hedge of the Company’s net investment in a euro-based subsidiary.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter, under the spot-to-spot method. The Company recognizes the impact of all other changes in fair value of the derivative, which represents the interest rate differential of the cross-currency swap, through interest expense. For the three months ended July 30, 2022 and July 31, 2021, the Company recorded gains of $0.3 million and $0.1 million, respectively, in interest expense, net in the condensed consolidated statements of income.

Interest rate swaps

The Company has interest rate swaps, maturing on August 31, 2023, with a notional value of $100.0 million, to manage its exposure and to mitigate the impact of interest rate variability. The interest rate swaps are designated as cash flow hedges.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter. The effective portion of the periodic changes in fair value is recognized in AOCI. Subsequently, the accumulated gains and losses recorded in AOCI are reclassified to income in the period during which the hedged cash flow impacts earnings, which are expected to be immaterial over the next 12 months. No ineffectiveness was recognized in the three months ended July 30, 2022 or July 31, 2021.

Derivatives not designated as hedges

The Company uses short-term foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. These forward contracts are not designated as hedging instruments. Gains and losses on these forward contracts are recognized in other income, net, along with the foreign currency gains and losses on monetary assets and liabilities in the condensed consolidated statements of income.

As of July 30, 2022 and April 30, 2022, the Company held foreign currency forward contracts with a notional value of $44.1 million and $38.6 million, respectively. During the three months ended July 30, 2022, the Company recognized a loss of $0.4 million related to foreign currency forward contracts in the condensed consolidated statements of income. During the three months ended July 31, 2021, an immaterial gain was recognized in the condensed consolidated statements of income.

Table of Contents

Fair value of derivative instruments on the balance sheet

The fair value of derivative instruments are classified as Level 2 within the fair value hierarchy and are recorded in the balance sheets as follows:


		Asset/(Liability)
(in millions)	Financial Statement Caption	July 30, 2022			April 30, 2022
Derivatives designated as hedging instruments:
Net investment hedges	Other long-term assets	$	3.9		$	1.9
Interest rate swaps	Other long-term assets	$	3.0		$	3.0
Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	$	0.1		$	—
Foreign currency forward contracts	Other accrued liabilities	$	(0.1	)	$	(0.2	)

Effect of derivative instruments on comprehensive income (loss)

Gross amounts recorded in other comprehensive income (loss) were as follows:


	Three Months Ended
(in millions)	July 30, 2022		July 31, 2021
Net investment hedges	$	2.0	$	1.1
Interest rate swaps		—		—
Total	$	2.0	$	1.1

Note 7. Debt

A summary of debt is shown below:


(in millions)	July 30, 2022			April 30, 2022
Term loan	$	203.1		$	206.3
Other debt		4.8			5.1
Unamortized debt issuance costs		(0.7	)		(0.9	)
Total debt		207.2			210.5
Less: current maturities		(13.0	)		(13.0	)
Total long-term debt	$	194.2		$	197.5

Revolving credit facility/term loan

The Company is a party to an Amended and Restated Credit Agreement (“Credit Agreement”) with Bank of America, N.A., as Administrative Agent, and Wells Fargo Bank, N.A. The Credit Agreement terminates in September 2023 and consists of a senior unsecured revolving credit facility (“Revolving Credit Facility”) of $200.0 million and a senior unsecured term loan (“Term Loan”) of $250.0 million. In addition, the Company has an option to increase the size of the Revolving Credit Facility and Term Loan by up to an additional $200.0 million, subject to customary conditions and approval of the lenders providing new commitments. The Credit Agreement is guaranteed by the Company’s wholly-owned U.S. subsidiaries. For the Term Loan, the Company is required to make quarterly principal payments of 1.25% of the original Term Loan ($3.1 million) through maturity, with the remaining balance due on September 12, 2023.

On December 10, 2021, the Company entered into a First Amendment to the Credit Agreement (“First Amendment”). The First Amendment amended and restated the Credit Agreement to provide, among other things, that upon the occurrence of certain events, the interest rate calculation method will generally transition from the London Interbank Offered Rate (“LIBOR”) to an alternate reference rate, including the Secured Overnight Financing Rate (“SOFR”) for U.S. dollar denominated borrowings.

Outstanding borrowings under the Credit Agreement bear interest at variable rates based on the type of borrowing and the Company’s debt to EBITDA financial ratio, as defined in the Credit Agreement. The weighted-average interest rate on outstanding borrowings under the Credit Agreement was approximately 3.6% as of July 30, 2022. The Credit Agreement contains customary representations and warranties, financial covenants, restrictive covenants and events of default. As of July 30, 2022, the Company was in compliance with all the covenants in the Credit Agreement.

Table of Contents

Other debt

One of the Company’s European subsidiaries has debt that consists of three notes with maturities ranging from 2023 to 2031. The weighted-average interest rate on this debt was approximately 1.4% at July 30, 2022 and $0.5 million of the debt was classified as short-term.

Note 8. Shareholders’ Equity

Share buyback program

On March 31, 2021, the Board of Directors authorized the purchase of up to $100.0 million of the Company’s outstanding common stock through March 31, 2023. On June 16, 2022, the Board of Directors authorized an increase in the share buyback program of an additional $100.0 million, and also extended the expiration from March 31, 2023 to June 14, 2024. Such purchases may be made on the open market, in private transactions or pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

The following table summarizes the Company’s stock buyback activity under this share buyback program:


	Three Months Ended
(in millions, except share and per share data)	July 30, 2022		July 31, 2021
Shares purchased		317,635		157,513
Average price per share	$	37.43	$	48.35
Total cost	$	11.9	$	7.6

As of July 30, 2022, a total of 1,910,774 shares have been purchased at a total cost of $83.1 million since the commencement of the share buyback program. All purchased shares were retired and are reflected as a reduction of common stock for the par value of shares, with the excess applied as a reduction to retained earnings. As of July 30, 2022, the dollar value of shares that remained available to be purchased by the Company under this share buyback program was $116.9 million.

Dividends

The Company paid dividends totaling $5.0 million and $5.2 million in the three months ended July 30, 2022 and July 31, 2021, respectively.

Accumulated other comprehensive income (loss)

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. A summary of changes in AOCI, net of tax is shown below:


	Three Months Ended July 30, 2022
(in millions)	Currency Translation Adjustments			Derivative Instruments			Total
Balance at beginning of period	$	(30.5	)	$	3.7		$	(26.8	)
Other comprehensive income (loss)		(10.9	)		2.0			(8.9	)
Tax (expense) benefit		-			(0.5	)		(0.5	)
Net other comprehensive income (loss)		(10.9	)		1.5			(9.4	)
Balance at the end of period	$	(41.4	)	$	5.2		$	(36.2	)


	Three Months Ended July 31, 2021
(in millions)	Currency Translation Adjustments			Derivative Instruments			Total
Balance at beginning of period	$	11.5		$	(5.4	)	$	6.1
Other comprehensive income (loss)		(3.9	)		1.1			(2.8	)
Tax (expense) benefit		(0.2	)		(0.2	)		(0.4	)
Net other comprehensive income (loss)		(4.1	)		0.9			(3.2	)
Balance at the end of period	$	7.4		$	(4.5	)	$	2.9

Table of Contents

Stock-based compensation

On June 16, 2022, the Company's Board of Directors, on the recommendation of the Compensation Committee, adopted the Methode Electronics, Inc. 2022 Omnibus Incentive Plan (the “2022 Incentive Plan”), subject to the approval of the Company's stockholders. The 2022 Incentive Plan provides for discretionary grants of stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units and performance grants to employees and directors.

The 2022 Incentive Plan provides that upon approval of the 2022 Incentive Plan by the Company's stockholders, no further awards shall be granted under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (“2014 Plan”). If the 2022 Incentive Plan is approved, subject to adjustment as provided in the 2022 Incentive Plan and the 2022 Incentive Plan’s share counting provisions, the number of shares of the Company's common stock that will initially be available for all awards under the 2022 Incentive Plan is 5,550,000, less one share for every one share of common stock subject to an option or SAR award granted after April 30, 2022 under the 2014 Plan and 2.28 shares for every one share that was subject to an award other than an option or SAR granted after April 30, 2022 under the 2014 Plan.

The Company has granted stock options, restricted stock awards (“RSAs”), performance units (“PUs”), restricted stock units (“RSUs”) and stock awards to employees and non-employee directors under 2014 Plan, the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”), the Methode Electronics, Inc. 2007 Stock Plan (“2007 Plan”) and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company can no longer make grants under the 2010 Plan, 2007 Plan and 2004 Plan. The number of shares of common stock originally authorized under the 2014 Plan is 3,000,000. As of July 30, 2022, there were 17,269 shares available for award under the 2014 Plan.

Restricted stock awards and performance units

As of July 30, 2022, the Company had 928,412 RSAs outstanding which will be earned based on the achievement of an earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) measure for fiscal 2025. The RSAs will vest ranging from 0% (for performance below threshold) to 100% (target performance) based on the achievement of the EBITDA performance measure and continued employment. In addition, if the target performance is exceeded, an additional 464,206 PUs can be earned that will be settled in cash. At the discretion of the Compensation Committee, the PUs may be settled in shares of common stock.

The fair value of the RSAs was based on the closing stock price on the date of grant and the RSAs earn dividend equivalents during the vesting period, which are forfeitable if the RSAs do not vest. Compensation expense for the RSAs is recognized when it is probable the minimum threshold performance criteria will be achieved. Compensation expense for the PUs is recognized when it is probable that the target performance criteria will be exceeded. The Company assesses the probability of vesting at each balance sheet date and adjusts compensation costs based on the probability assessment. The cash-settled PUs represent a non-equity unit with a conversion value equal to the fair market value of a share of the Company’s common stock on the vesting date. The PUs are classified as liability awards due to the cash settlement feature and are re-measured at each balance sheet date. In accordance with Accounting Standards Codification 718, based on projections of the Company’s current business portfolio, no compensation expense has not been recognized for the RSAs or PUs to-date, as the performance conditions are not probable of being met. Unrecognized stock-based compensation expense at target level of performance is $26.5 million as of July 30, 2022, which, subject to the performance conditions being met, will be recognized through fiscal 2025.

Restricted stock units

RSUs granted under the 2014 Plan vest over a pre-determined period of time, up to five years from the date of grant. The fair value of the RSUs granted are based on the closing stock price on the date of grant and earn dividend equivalents during the vesting periods, which are forfeitable if the RSUs don’t vest.

The following table summarizes RSU activity under the 2014 Plan:


	Restricted Stock Units			Weighted average grant date fair value
Non-vested at April 30, 2022		936,391		$	29.16
Awarded		52,832		$	39.44
Vested		—		$	—
Forfeited		(734	)	$	48.41
Non-vested at July 30, 2022		988,489		$	29.70

Under the various stock plans, common stock underlying vested RSUs held by certain executives will not be delivered until termination of employment or a change of control of the Company. As of July 30, 2022, common stock to be delivered to these executives totaled 577,055 shares.

Table of Contents

Director awards

The Company grants stock awards to its non-employee directors as a component of their compensation. The stock awards vest immediately upon grant. Non-employee directors may elect to defer receipt of their shares under the Company’s non-qualified deferred compensation plan. In the three months ended July 30, 2022, the Company granted 42,735 shares, of which 27,195 shares were deferred. All dividends on deferred shares are reinvested into additional deferred shares based on the closing price of the Company’s common stock on the dividend payment date. Deferred shares will be settled with shares of common stock upon each director’s retirement from the Company’s Board of Directors. As of July 30, 2022, there were 45,304 deferred shares outstanding.

Stock options

The following table summarizes combined stock option activity under the 2010 Plan:


	Shares		Weighted average exercise price		Weighted- average life (years)		Aggregate intrinsic value (in millions)
Outstanding and exercisable at April 30, 2022		60,000	$	37.01		2.2	$	0.5
Exercised		—	$	—
Forfeited		—	$	—
Outstanding and exercisable at July 30, 2022		60,000	$	37.01		1.9	$	0.3

The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on that date.

Stock-based compensation expense

All stock-based awards to employees and non-employee directors are recognized in selling and administrative expenses on the condensed consolidated statements of income. Awards subject to graded vesting are recognized using the accelerated recognition method over the requisite service period. The table below summarizes the stock-based compensation expense related to the equity awards:


	Three Months Ended
(in millions)	July 30, 2022		July 31, 2021
RSUs	$	2.4	$	2.5
Deferred director awards		1.0		0.8
Director awards		0.6		0.7
Total stock-based compensation expense	$	4.0	$	4.0

Table of Contents

Note 9. Income per Share

Basic income per share is calculated by dividing net income by the weighted average number of common shares outstanding for the applicable period but excludes any contingently issued shares where the contingency has not been resolved. The weighted average number of common shares used in the diluted income per share calculation is determined using the treasury stock method which includes the effect of all potential dilutive common shares outstanding during the period.

The following table sets forth the computation of basic and diluted income per share:


	Three Months Ended
	July 30, 2022		July 31, 2021
Numerator:
Net income (in millions)	$	21.5	$	29.1

Denominator:
Denominator for basic income per share - weighted average shares outstanding and vested/unissued restricted stock units		36,565,975		37,939,488
Dilutive potential common shares		649,825		518,470
Denominator for diluted income per share		37,215,800		38,457,958

Basic and diluted income per share:
Basic income per share	$	0.59	$	0.77
Diluted income per share	$	0.58	$	0.76

Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding		928,534		928,412

Note 10. Segment Information

An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenues and incur expenses, and about which separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. The CODM is the Company’s President and Chief Executive Officer (“CEO”). The Company has four reporting segments as described below.

The Automotive segment supplies electronic and electro-mechanical devices and related products to automobile OEMs, either directly or through their tiered suppliers. Products include integrated center consoles, hidden switches, ergonomic switches, transmission lead-frames, LED-based lighting and sensors, which incorporate magneto-elastic sensing and other technologies that monitor the operation or status of a component or system.

The Industrial segment manufactures external lighting solutions, industrial safety radio remote controls, braided flexible cables, current-carrying laminated busbars and devices, custom power-product assemblies, such as our PowerRail® solution, high-current low-voltage flexible power cabling systems and powder-coated busbars that are used in various markets and applications, including aerospace, computers, industrial, power conversion, military, telecommunications and transportation.

The Interface segment provides a variety of copper and fiber-optic interface and interface solutions for the appliance, commercial food service, construction, consumer, material handling, point-of-sale and telecommunications markets. Solutions include copper transceivers and solid-state field-effect consumer touch panels.

The Medical segment is made up of the Company’s medical device business, Dabir Surfaces, with its surface support technology aimed at pressure injury prevention. Methode has developed the technology for use by patients who are immobilized or otherwise at risk for pressure injuries, including patients undergoing long-duration surgical procedures.

Table of Contents

The tables below present information about the Company’s reportable segments:


	Three Months Ended July 30, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	177.3		$	93.7		$	13.0	$	0.7		$	(2.3	)	$	282.4
Transfers between segments		(0.7	)		(1.6	)		—		—			2.3			—
Net sales to unaffiliated customers	$	176.6		$	92.1		$	13.0	$	0.7		$	—		$	282.4

Income (loss) from operations	$	14.7		$	22.4		$	1.6	$	(1.5	)	$	(15.4	)	$	21.8
Interest expense, net																—
Other income, net																(4.1	)
Income before income taxes															$	25.9


	Three Months Ended July 31, 2021
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	197.0		$	81.2		$	12.7	$	0.8		$	(3.9	)	$	287.8
Transfers between segments		(1.2	)		(2.7	)		—		—			3.9			—
Net sales to unaffiliated customers	$	195.8		$	78.5		$	12.7	$	0.8		$	—		$	287.8

Income (loss) from operations	$	27.3		$	20.2		$	1.1	$	(1.2	)	$	(13.3	)	$	34.1
Interest expense, net																1.1
Other income, net																(1.8	)
Income before income taxes															$	34.8


(in millions)	July 30, 2022		April 30, 2022
Identifiable assets:
Automotive	$	700.8	$	689.8
Industrial		460.5		455.3
Interface		107.9		108.1
Medical		7.3		7.9
Eliminations/Corporate		113.4		128.0
Total identifiable assets	$	1,389.9	$	1,389.1

Table of Contents

Note 11. Contingencies

Certain litigation arising in the normal course of business is pending against us. The Company is, from time-to-time, subject to various legal actions and claims incidental to our business, including those arising out of alleged defects, breach of contracts, employment-related matters, environmental matters and intellectual property matters. The Company considers insurance coverage and third-party indemnification when determining required accruals for pending litigation and claims. Although the outcome of potential legal actions and claims cannot be determined, it is the Company's opinion, based on the information available, that it has adequate reserves for these liabilities.

Hetronic Germany-GmbH Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. The Company became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, the Company terminated all of its agreements with the Fuchs companies. On June 20, 2014, the Company filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, the Company amended its complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties currently are preparing post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. Hetronic has opposed that petition. The Supreme Court has requested the views of the Solicitor General on the petition for certiorari. Like any judgment, particularly any judgment involving defendants outside of the United States, there is no guarantee that the Company will be able to collect all or any portion of the judgment.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

As used herein, “we,” “us,” “our,” the “Company” or “Methode” means Methode Electronics, Inc. and its subsidiaries.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (“Quarterly Report”) includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect, when made, our current views with respect to current events and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to our operations and business environment, which may cause our actual results to be materially different from any future results, express or implied, by such forward-looking statements. All statements that address future operating, financial or business performance or our strategies or expectations are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “outlook” or “continue,” and other comparable terminology. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following:

•

Dependence on our supply chain, including semiconductor suppliers;

•

Impact from pandemics, such as the COVID-19 pandemic;

•

Dependence on the automotive and commercial vehicle industries;

•

Impact from inflation;

•

Dependence on a small number of large customers, including one large automotive customer;

•

Dependence on the availability and price of materials;

•

Risks related to conducting global operations;

•

Ability to withstand pricing pressures, including price reductions;

•

Currency fluctuations;

•

Timing and magnitude of costs associated with restructuring activities;

•

Failure to attract and retain qualified personnel;

•

Recognition of goodwill and other intangible asset impairment charges;

•

Timing, quality and cost of new program launches;

•

International trade disputes resulting in tariffs and our ability to mitigate tariffs;

•

Adjustments to compensation expense for performance-based awards;

•

Investment in programs prior to the recognition of revenue;

•

Ability to compete effectively;

•

Impact from production delays or cancelled orders;

•

Ability to withstand business interruptions;

•

Ability to keep pace with rapid technological changes;

•

Breaches to our information technology systems;

•

Ability to avoid design or manufacturing defects;

•

Ability to manage our debt levels and any restrictions thereunder;

•

Income tax rate fluctuations;

•

Ability to protect our intellectual property;

•

Ability to successfully benefit from acquisitions and divestitures;

•

Impact from climate change and related regulations;

•

Judgments related to accounting for tax positions; and

•

Costs associated with environmental, health and safety regulations.

Additional details and factors are discussed under the caption “Risk Factors” in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended April 30, 2022. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. Any forward-looking statements made by us speak only as of the date on which they are made. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, subsequent events or otherwise.

Table of Contents

Overview

We are a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. We design, engineer and produce mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing our broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

Our solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment, consumer appliance and medical devices. Our business is managed on a segment basis, with those segments being Automotive, Industrial, Interface and Medical.

COVID-19 Pandemic Impact

The COVID-19 pandemic and the ongoing measures to reduce its spread have negatively impacted the global economy, disrupted consumer and customer demand and global supply chains, and resulted in manufacturing inefficiencies and increased freight costs due to global capacity constraints. Beginning late in the fourth quarter of fiscal 2022 and continuing into the first quarter of fiscal 2023, various regions in China, including regions where we and our customers have operations, were subjected to lock-downs imposed by governmental authorities to mitigate the spread of COVID-19 in those areas. The resulting industry-wide production interruptions adversely impacted our results of operations in the three months ended July 30, 2022.

Any future resurgence of COVID-19, and its related impacts, could negatively impact our business and future results of operations. The extent of the impact will depend on a number of evolving and uncertain factors, including the duration and spread of COVID-19 (and its variants), the rate of vaccinations, actions taken by governmental authorities to further restrict business operations and social activity and impose travel restrictions, shifting consumer demand, the ability of our supply chain to deliver in a timely and cost-effective manner, the ability of our employees and manufacturing facilities to operate efficiently and effectively, the continued viability and financial stability of our customers and suppliers and future access to capital. We continue to focus on effectively managing the unprecedented challenges and uncertainties of the pandemic on a global basis.

Global Supply Chain Disruptions

We continue to experience business interruptions, including customer shutdowns and increased material and logistics costs, labor shortages, and most significantly, impacts from the worldwide semiconductor supply shortage. The semiconductor supply shortage is due, in part, to increased demand across multiple industries, including the automotive industry, resulting in a slowdown in their production schedules. The semiconductor supply shortage is also impacting our supply chain and our ability to meet demand at some of our non-automotive customers. We expect this semiconductor shortage to have a continued impact on our operating results and financial condition for the remainder of fiscal 2023.

Impacts of Macroeconomic and Geopolitical Conditions

Adverse macroeconomic conditions, including but not limited to inflation, slower growth or recession, new or increased tariffs, changes to fiscal and monetary policy, higher interest rates, wage and commodity inflation and currency fluctuations could adversely affect demand for our products. In addition, the Russia/Ukraine conflict has resulted in, among other things, economic sanctions imposed by the international community which have impacted the global economy and given rise to potential global security issues that may adversely affect international business and economic conditions. Although we have no operations in Russia or Ukraine, certain of our customers and suppliers have been negatively impacted by these events, which in turn has impacted markets where we do business, including Europe and Asia. The economic sanctions imposed on Russia has further increased existing global supply chain, logistics, and inflationary challenges. For example, in response to the sanctions imposed on Russia by Western countries, Russia has reduced the volume of natural gas it sends to European countries, which has resulted in, and could continue to result in increased energy costs for our EMEA operations. If Russia further reduces or turns off energy supplies to Europe, our EMEA operations could be adversely affected.

Table of Contents

Consolidated Results of Operations

The table below compares our results of operations between the three months ended July 30, 2022 and the three months ended July 31, 2021:


	Three Months Ended
(in millions)	July 30, 2022			July 31, 2021
Net sales	$	282.4		$	287.8
Cost of products sold		220.6			216.1
Gross profit		61.8			71.7
Selling and administrative expenses		35.3			32.8
Amortization of intangibles		4.7			4.8
Interest expense, net		-			1.1
Other income, net		(4.1	)		(1.8	)
Income tax expense		4.4			5.7
Net income	$	21.5		$	29.1

Net sales

Net sales decreased $5.4 million, or 1.9%, to $282.4 million in the three months ended July 30, 2022, compared to $287.8 million in the three months ended July 31, 2021. The decrease was primarily due to lower sales in the Automotive segment, partially offset by higher sales in the Industrial segment. Net sales were unfavorably impacted by foreign currency translation of $14.2 million, primarily due to the strengthening of the U.S. dollar relative to the euro and Chinese renminbi. This was partially offset by customer cost recoveries for spot buys of materials and premium freight costs of $11.1 million. Excluding the impact of foreign currency translation and customer cost recoveries, net sales decreased $2.3 million, or 0.8%.

Cost of products sold

Cost of products sold increased $4.5 million, or 2.1%, to $220.6 million (78.1% of net sales) in the three months ended July 30, 2022, compared to $216.1 million (75.1% of net sales) in the three months ended July 31, 2021. Excluding foreign currency translation, cost of products sold increased $14.8 million. The increase was primarily due to higher material costs of $13.3 million as a result of inflationary pressures and costs related to spot buys of materials.

Gross profit margin

Gross profit margin was 21.9% of net sales in the three months ended July 30, 2022, compared to 24.9% of net sales in the three months ended July 31, 2021. The decrease was due to higher material and other costs associated with supply chain disruptions and lower sales volumes.

Selling and administrative expenses

Selling and administrative expenses increased $2.5 million, or 7.6%, to $35.3 million (12.5% of net sales) in the three months ended July 30, 2022, compared to $32.8 million (11.4% of net sales) in the three months ended July 31, 2021. Excluding foreign currency translation, selling and administrative expenses increased $3.6 million. The increase was primarily due to higher salary expense, travel expense and other general administrative expenses.

Amortization of intangibles

Amortization of intangibles was $4.7 million in the three months ended July 30, 2022, compared to $4.8 million in the three months ended July 31, 2021, respectively.

Interest expense, net

Interest expense, net was zero in the three months ended July 30, 2022, compared to $1.1 million in the three months ended July 31, 2021.

The decrease was due to higher interest income of $0.7 million and lower interest expense of $0.4 million recognized during the period. The increase in interest income was primarily from our cash holdings as a result of increasing interest rates. The decrease in interest expense was due to lower average borrowings.

Other income, net

Other income, net was $4.1 million in the three months ended July 30, 2022, compared to $1.8 million in the three months ended July 31, 2021. In the three months ended July 30, 2022, we received $4.1 million of international government assistance with respect to the COVID-19 pandemic, compared to $1.9 million in the three months ended July 31, 2021.

Table of Contents

Income tax expense

Income tax expense was $4.4 million (17.0% effective tax rate) in the three months ended July 30, 2022, compared to $5.7 million (16.4% effective tax rate) in the three months ended July 31, 2021. The effective tax rate for the three months ended July 30, 2022 was lower than the U.S. statutory tax rate primarily due income derived from foreign operations with lower statutory tax rates partially offset by non-deductible expenses. The effective tax rate for the three months ended July 31, 2021 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates.

Net income

Net income decreased $7.6 million, or 26.1%, to $21.5 million in three months ended July 30, 2022, compared to $29.1 million in three months ended July 31, 2021. Net income was unfavorably impacted by foreign currency translation of $2.9 million. Excluding foreign currency translation, net income decreased $4.7 million as a result of the reasons described above.

Operating Segments

Automotive


	Three Months Ended
($ in millions)	July 30, 2022			July 31, 2021
Net sales
North America	$	94.7		$	99.1
EMEA	$	52.1		$	57.8
Asia	$	29.8		$	38.9
Net sales	$	176.6		$	195.8
Gross profit	$	29.4		$	41.7
As a percent of net sales		16.6	%		21.3	%
Income from operations	$	14.7		$	27.3
As a percent of net sales		8.3	%		13.9	%

Net sales

Automotive segment net sales decreased $19.2 million, or 9.8%, to $176.6 million in the three months ended July 30, 2022, compared to $195.8 million in the three months ended July 31, 2021. Net sales were unfavorably impacted by foreign currency translation of $8.9 million. This was partially offset by customer cost recoveries from spot buys of materials and premium freight costs of $9.1 million (primarily in North America). Excluding foreign currency translation and customer cost recoveries, net sales decreased $19.4 million, or 9.9%.

Net sales in North America decreased $4.4 million to $94.7 million in the three months ended July 30, 2022, compared to $99.1 million in the three months ended July 31, 2021. Net sales in North America benefitted from customer cost recoveries from spot buys of materials and premium freight costs of $7.9 million. Excluding customer cost recoveries, net sales decreased $12.3 million primarily due to a major program roll-off, partially offset by higher vehicle lighting product sales. Net sales in EMEA decreased $5.7 million to $52.1 million in the three months ended July 30, 2022, compared to $57.8 million in the three months ended July 31, 2021. Net sales in EMEA benefitted from customer cost recoveries from spot buys of materials and premium freight costs of $1.2 million. However, the weaker euro, relative to the U.S. dollar, decreased net sales in EMEA by $7.7 million. Excluding customer cost recoveries and the impact of foreign currency translation, net sales in EMEA increased by $0.8 million. Net sales in Asia decreased $9.1 million to $29.8 million in the three months ended July 30, 2022, compared to $38.9 million in the three months ended July 31, 2021. The weaker Chinese renminbi, relative to the U.S. dollar, decreased net sales in Asia by $1.3 million. Excluding the impact of foreign currency translation, Asia net sales decreased $7.8 million primarily due to COVID-19 lockdowns in China.

Gross profit

Automotive segment gross profit decreased $12.3 million, or 29.5%, to $29.4 million in the three months ended July 30, 2022, compared to $41.7 million in the three months ended July 31, 2021. Excluding the impact of foreign currency translation, gross profit decreased $10.2 million. Gross profit margins decreased to 16.6% in the three months ended July 30, 2022, compared to 21.3% in the three months ended July 31, 2021. The decrease in gross profit margins was due to lower sales volumes, the result of inflationary pressures and costs related to spot buys of materials and the impact from product mix.

Income from operations

Automotive segment income from operations decreased $12.6 million, or 46.2%, to $14.7 million in the three months ended July 30, 2022, compared to $27.3 million in the three months ended July 31, 2021. Excluding the impact of foreign currency translation, income from operations decreased $11.4 million. The decrease was primarily due to lower gross profit and higher selling and administrative expenses. Selling and administrative expenses increased due to higher salary expense as a result of wage inflation.

Table of Contents

Industrial


	Three Months Ended
($ in millions)	July 30, 2022			July 31, 2021
Net sales	$	92.1		$	78.5
Gross profit	$	30.4		$	28.5
As a percent of net sales		33.0	%		36.3	%
Income from operations	$	22.4		$	20.2
As a percent of net sales		24.3	%		25.7	%

Net sales

Industrial segment net sales increased $13.6 million, or 17.3%, to $92.1 million in the three months ended July 30, 2022, compared to $78.5 million in the three months ended July 31, 2021. Net sales were unfavorably impacted by foreign currency translation of $5.2 million. This was partially offset by customer cost recoveries from spot buys of materials and premium freight costs of $1.4 million. Excluding the impact of foreign currency translation and customer cost recoveries, net sales increased $17.4 million, or 22.2%, primarily due to higher sales volumes of all product categories in the Industrial segment.

Gross profit

Industrial segment gross profit increased $1.9 million, or 6.7%, to $30.4 million in the three months ended July 30, 2022, compared to $28.5 million in the three months ended July 31, 2021. Excluding the impact of foreign currency translation, gross profit increased $3.7 million. Gross profit margins decreased to 33.0% in the three months ended July 30, 2022, compared to 36.3% in the three months ended July 31, 2021. The decrease in gross profit margins was due to higher material costs as a result of supply chain disruptions.

Income from operations

Industrial segment income from operations increased $2.2 million, or 10.9%, to $22.4 million in the three months ended July 30, 2022, compared to $20.2 million in the three months ended July 31, 2021. Excluding the impact of foreign currency translation, income from operations increased $3.7 million. The increase was primarily due to higher gross profit. Selling and administrative expenses were relatively unchanged.

Interface


	Three Months Ended
($ in millions)	July 30, 2022			July 31, 2021
Net sales	$	13.0		$	12.7
Gross profit	$	2.2		$	1.7
As a percent of net sales		16.9	%		13.4	%
Income from operations	$	1.6		$	1.1
As a percent of net sales		12.3	%		8.7	%

Net sales

Interface segment net sales increased $0.3 million, or 2.4%, to $13.0 million in the three months ended July 30, 2022, compared to $12.7 million in the three months ended July 31, 2021. The increase was primarily due to higher sales of data solutions products as a result of customer cost recoveries of spot buys of materials. This was partially offset by lower sales volumes of appliance products, which were negatively impacted by a shortage of semiconductor chips.

Gross profit

Interface segment gross profit increased $0.5 million, or 29.4%, to $2.2 million in the three months ended July 30, 2022, compared to $1.7 million in the three months ended July 31, 2021. Gross profit margins increased to 16.9% in the three months ended July 30, 2022, compared to 13.4% in the three months ended July 31, 2021. The increase in gross profit margins was primarily due to product mix.

Income from operations

Interface segment income from operations increased $0.5 million, or 45.5%, to $1.6 million in the three months ended July 30, 2022, compared to $1.1 million in the three months ended July 31, 2021. The increase was due to higher gross profit.

Table of Contents

Medical


	Three Months Ended
(in millions)	July 30, 2022			July 31, 2021
Net sales	$	0.7		$	0.8
Gross profit	$	(0.2	)	$	—
Loss from operations	$	(1.5	)	$	(1.2	)

Net sales

Medical segment net sales decreased $0.1 million to $0.7 million in the three months ended July 30, 2022, compared to $0.8 million in the three months ended July 31, 2021.

Gross profit

Medical segment gross profit was a loss of $0.2 million in the three months ended July 30, 2022 compared to break-even in the three months ended July 31, 2021. Gross profit was impacted by higher operating costs and lower net sales in the three months ended July 30, 2022.

Loss from operations

Medical segment loss from operations increased $0.3 million to $1.5 million in the three months ended July 30, 2022, compared to $1.2 million in the three months ended July 31, 2021. The increase in the loss was primarily due to lower gross profit.

Financial Condition, Liquidity and Capital Resources

Our liquidity requirements are primarily to fund our business operations, including capital expenditures and working capital requirements, as well as to fund debt service requirements, dividends and stock repurchases. Our primary sources of liquidity are cash flows from operations, existing cash balances and borrowings under our senior unsecured credit agreement. We believe our liquidity position will be sufficient to fund our existing operations and current commitments for at least the next twelve months. However, if economic conditions remain impacted for longer than we expect due to the COVID-19 pandemic, supply chain disruptions, inflationary pressure or other geopolitical risks, including the Russia-Ukraine war, our liquidity position could be severely impacted.

As of July 30, 2022, we had $152.4 million of cash and cash equivalents, of which $104.7 million was held in subsidiaries outside the U.S. Cash held by these subsidiaries is used to fund operational activities and can be repatriated, primarily through the payment of dividends and the repayment of intercompany loans, without creating material additional income tax expense.

Share Buyback Program

On March 31, 2021, the Board of Directors authorized the purchase of up to $100.0 million of our common stock. On June 16, 2022, the Board of Directors authorized an increase in the existing share buyback program of an additional $100.0 million, and also extended the expiration from March 31, 2023 to June 14, 2024. Such purchases may be made on the open market, in private transactions or pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. As of July 30, 2022, a total of 1,910,774 shares have been purchased at a total cost of $83.1 million since the commencement of the share buyback program. As of July 30, 2022, the dollar value of shares that remained available to be purchased under this share buyback program was $116.9 million.

Credit Agreement

Our senior unsecured credit agreement provides for a $200.0 million revolving credit facility and a $250.0 million term loan. As of July 30, 2022, no principal was outstanding under the revolving credit facility and we have $199.9 million of availability under the revolving credit facility. As of July 30, 2022, $203.1 million in principal was outstanding under the term loan. The term loan matures in September 2023 and requires quarterly principal payments of $3.1 million over the five-year term, with the remaining balance due upon maturity. We were in compliance with all covenants under the senior unsecured credit agreement as of July 30, 2022. For further information, see Note 7, “Debt” to the condensed consolidated financial statements included in this Quarterly Report.

On December 10, 2021, we entered into an amendment to the senior unsecured credit agreement to provide, among other things, that upon the occurrence of certain events, the interest rate calculation method will generally transition from the London Interbank Offered Rate (“LIBOR”) to an alternate reference rate, including the Secured Overnight Financing Rate (“SOFR”) for U.S. dollar denominated borrowings. The consequences of the discontinuance of LIBOR cannot be entirely predicted but could result in an increase in our cost of borrowing.

Table of Contents

Our senior unsecured credit agreement provides an option to increase the size of our revolving credit facility and term loan by an additional $200.0 million, subject to customary conditions and approval of the lenders providing the new commitments. There can be no assurance that lenders will approve additional commitments under current circumstances. As a result of the impacts of the COVID-19 pandemic, we may be required to raise additional capital and our access to, and cost of, financing will depend on, among other things, global economic conditions, conditions in the global financing markets, the availability of sufficient amounts of financing, and our future prospects.

Cash Flows


	Three Months Ended
(in millions)	July 30, 2022			July 31, 2021
Operating activities:
Net income	$	21.5		$	29.1
Non-cash items		14.9			16.0
Changes in operating assets and liabilities		(23.7	)		(35.4	)
Net cash provided by operating activities		12.7			9.7
Net cash used in investing activities		(9.6	)		(15.4	)
Net cash used in financing activities		(20.8	)		(18.3	)
Effect of foreign currency exchange rate changes on cash and cash equivalents		(1.9	)		(1.3	)
Decrease in cash and cash equivalents		(19.6	)		(25.3	)
Cash and cash equivalents at beginning of the period		172.0			233.2
Cash and cash equivalents at end of the period	$	152.4		$	207.9

Operating activities

Net cash provided by operating activities increased $3.0 million to $12.7 million in the three months ended July 30, 2022, compared to $9.7 million in the three months ended July 31, 2021. The increase was due to lower cash outflows related to changes in operating assets and liabilities, partially offset by lower net income adjusted for non-cash items. The $23.7 million of cash outflows for operating assets and liabilities in the three months ended July 30, 2022 was primarily due to higher accounts receivable and inventory (as a result of global supply chain and logistics disruptions), partially offset by higher accounts payable.

Investing activities

Net cash used in investing activities was $9.6 million in the three months ended July 30, 2022, compared to $15.4 million in the three months ended July 31, 2021. Capital expenditures were $9.6 million and $15.9 million in the three months ended July 30, 2022 and July 31, 2021, respectively. We received $0.5 million of cash from the sale of property, plant and equipment in the three months ended July 31, 2021.

Financing activities

Net cash used in financing activities was $20.8 million in the three months ended July 30, 2022, compared to $18.3 million in the three months ended July 31, 2021. In the three months ended July 30, 2022, we used $11.9 million of cash for the purchase of shares under our share buyback program, compared to $8.4 million in the three months ended July 31, 2021. We paid cash dividends of $5.0 million in the three months ended July 30, 2022, compared to $5.2 million in the three months ended July 31, 2021. In the three months ended July 30, 2022, we paid $0.5 million in taxes related to the net share settlement of equity awards compared to $0.3 million in the three months ended July 31, 2021. In the three months ended July 30, 2022, we had repayments on our borrowings of $3.3 million, compared to $4.7 million in the three months ended July 31, 2021.

Recent Accounting Pronouncements

See Note 1, “Description of Business and Summary of Significant Accounting Policies” to the condensed consolidated financial statements included in Item 1.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements as defined under SEC rules.

Table of Contents

Legal Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. We became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, we terminated all of our agreements with the Fuchs companies. On June 20, 2014, we filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, we amended our complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

In the three months ended July 30, 2022 and July 31, 2021, we incurred Hetronic-related legal fees of $0.8 million and $0.7 million, respectively. These amounts are included in the selling and administrative expenses in the Industrial segment.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risks from foreign currency exchange, interest rates, and commodity prices, which could affect our operating results, financial position and cash flows. We manage a portion of these risks through use of derivative financial instruments in accordance with our policies. We do not enter into derivative financial instruments for speculative or trading purposes.

There has been no significant change in our exposure to market risk during the three months ended July 30, 2022. For a discussion of our exposure to market risk, refer to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” contained in our Annual Report on Form 10-K for the year ended April 30, 2022.

Item 4. Controls and Procedures

As of the end of the period covered by this quarterly report on Form 10-Q, we performed an evaluation under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and our Chief Financial Officer, of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). The Company’s disclosure controls and procedures are designed to ensure that the information required to be disclosed by the Company in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s applicable rules and forms. As a result of this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective.

There have been no changes in our internal control over financial reporting during the quarter ended July 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

Item 1A. Risk Factors

Our business, financial condition, results of operations and cash flows are subject to various ‎risks which could cause actual results to vary from recent results or from anticipated future results. There have ‎been no material changes to the risk factors previously disclosed in Part I - Item 1A, “Risk Factors” of our Form 10-K for the ‎year ended April 30, 2022.‎

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about our purchases of equity securities during the three months ended July 30, 2022:


Period	Total number of shares purchased		Average price paid per share		Total number of shares purchased as part of publicly announced plan		Approximate dollar value of shares that may yet be purchased under the program (in millions)
May 1, 2022 through May 28, 2022 (1)		10,679	$	44.61		-	$	28.8
May 29, 2022 through July 2, 2022		134,991	$	37.84		134,991	$	123.7
July 3, 2022 through July 30, 2022		182,644	$	37.13		182,644	$	116.9
(1) Represents shares of common stock that were surrendered by employees to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Item 6. Exhibits


Exhibit Number		Description

31.1		Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer
31.2		Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer
32*		Certification of Periodic Financial Report Pursuant to 18 U.S.C. Section 1350
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)


*		Indicates that the exhibit is being furnished with this report and not filed as part of it.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		METHODE ELECTRONICS, INC.

		By:	/s/ Ronald L.G. Tsoumas
			Ronald L.G. Tsoumas
			Chief Financial Officer
			(Principal Financial Officer)

Dated:	September 1, 2022